Clinical trial
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
NCT03471117
Study timeline
Study start (actual)2018-04-01Date precision: day
Registry last updated2026-07-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Chronic Kidney Diseasesunresolved
Interventions
PioglitazoneDRUG · verified · RxNorm: pioglitazone
PlaceboOTHER
Sponsors & collaborators
The University of Texas at Arlingtonlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03471117 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.